Literature DB >> 2321953

Analogs of oxalacetate as potential substrates for phosphoenolpyruvate carboxykinase.

P F Guidinger1, T Nowak.   

Abstract

Structural analogs of the substrate oxalacetate were examined as potential substrates and inhibitors for chicken liver mitochondrial phosphoenolpyruvate (P-enolpyruvate) carboxykinase. Steady-state kinetics were employed to characterize the inhibitory effects of these substrate analogs with the enzyme. Assays were carried out in both carboxylation and decarboxylation reaction directions. Pyruvate, beta-hydroxypyruvate, beta-mercaptopyruvate, beta-fluoropyruvate, DL-lactate, glycolate, glycoaldehyde, glyoxylate, glyphosate, and DL-aspartate showed no inhibitory effects by steady-state kinetics. Oxalate, acetopyruvate, and DL-, D-, and L-glycerate exhibited weak noncompetitive inhibition of the P-enolpyruvate carboxykinase-catalyzed reaction. DL-3-Nitro-2-hydroxypropionic acid, 3-nitro-2-oxopropionic acid, DL-malate, malonate, tartronate, and alpha-ketobutyrate all show weak inhibition with estimated inhibition constants greater than 20 nM. Several of these compounds were investigated by 31P NMR to determine if they function as phosphoryl acceptors for GTP. None of the compounds tested act as phosphoryl acceptors in the enzyme-catalyzed reaction. Chicken liver mitochondrial phosphoenolpyruvate carboxykinase shows a remarkably high degree of specificity at the binding site of oxalacetate.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2321953     DOI: 10.1016/0003-9861(90)90241-p

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  2 in total

Review 1.  Structural insights into the mechanism of phosphoenolpyruvate carboxykinase catalysis.

Authors:  Gerald M Carlson; Todd Holyoak
Journal:  J Biol Chem       Date:  2009-07-27       Impact factor: 5.157

2.  Hyperpolarized [(13)C]ketobutyrate, a molecular analog of pyruvate with modified specificity for LDH isoforms.

Authors:  Cornelius von Morze; Robert A Bok; Michael A Ohliger; Zihan Zhu; Daniel B Vigneron; John Kurhanewicz
Journal:  Magn Reson Med       Date:  2015-06-08       Impact factor: 4.668

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.